UNITAID IMPAACT4TB Research Group

Independent

SCHOLARLY PAPERS

1

DOWNLOADS

93

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Simultaneous Initiation of Dolutegravir-Based Antiretroviral Treatment and Once-Weekly Rifapentine and Isoniazid (3HP) for Tuberculosis Prevention in Antiretroviral-Naïve People with HIV: A Phase 1/2 Trial

Number of pages: 22 Posted: 12 Sep 2024
Johns Hopkins University - Division of Clinical Pharmacology, Aurum Institute, Aurum Institute, Aurum Institute, Johns Hopkins University, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Johns Hopkins University - Bloomberg School of Public Health, University of Cape Town (UCT), Aurum Institute, Aurum Institute, Aurum Institute, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Vanderbilt University - Medical Center, Johns Hopkins University, Aurum Institute, Independent and Independent
Downloads 93 (612,711)

Abstract:

Loading...

Tuberculosis, TB Preventive Treatment, HIV/AIDS, Drug-Drug Interaction Study